Automation of the Bull Protocol: A new perspective for heparinization.

Una Nueva Perspectiva para la Heparinización

Abstract

Introduction and Objective: Heparin is the most used anticoagulant for the treatment of thrombogenic pathologies and used in invasive procedures whether in cardiac surgery or hemodynamics, however its control and monitoring is of fundamental importance for the safety and hemostatic stability of the patient, aiming at this present The aim of this study is to automate the Bull protocol for use in the hospital and surgical setting, to compare the volume of heparin given empirically and calculated by the application, to bring safety to the professional regarding the dose administered to the patient.

Method: 50 patients were randomly selected, randomly divided into two groups with n=25 each group, who underwent cardiac surgery with baypass, from March to July 2021, in which serum levels of heparin were measured.

Results: In the group that was empirically administered, a higher dose of heparin was observed compared to the application group, the average heparin given by the application was 8.12 mL of heparin, while the empirical mode showed an average of 10.5 mL of heparin given to the patient demonstrating an average statistical difference between the application group and the empirical group of 2.38mL

Conclusion: In the present study, it was possible to notice that the automation of the Bull protocol presents heparinization stability even with lower doses compared to the empirical group